HIV prevention and treatment drug (capsid inhibitor) with long-acting formulation
UNAids warns that funding cuts and tightening civic space threaten progress against HIV. Six-month lenacapavir injections are rolling out in South Africa, with early results showing promise but concerns over access and equity persist as external aid declines.
The United States has begun a phased drawdown of PEPFAR in South Africa, citing policy disagreements and a belief that South Africa can sustain its HIV programs. Pretoria says it will continue treatment with domestic funding, while UN meetings seek clarity on future donor support.